fatigue on retatrutide Unapproved weight loss drug causes extreme side effects I just started retatrutide and

Individuals already taking GLP-1 receptor agonists for diabetes or weight management should continue their prescribed therapy as directed, but should not expect guaranteed cognitive benefits beyond those associated with improved metabolic health

As GLP-1 therapies become more widely used, its essential we pair them with clear, accessible guidance that helps patients maintain long-term health and minimize side effects

IDF Diabetes Atlas, 8th edn., 2017

As the graphic illustrates, the index for new prescriptions in 2023 was 104, thus four points above the 100 mark

Wegovy injection (semaglutide): This is the benchmark weekly GLP-1 injection